Examples include: (a) using objective measures to examine whether sleep-vascular risk synergism related to cognitive decline is independent of Aβ and tau pathology and (b) determine specific sleep and vascular disorders’ effects on slow wave and rapid eye movement sleep and their mediating role in increasing Aβ and tau accumulation. This evidence concerns the gene MAPT and vascular disorder.